LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 192 filers reported holding LEGEND BIOTECH CORP in Q2 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $376,920 | +11.5% | 5,604 | +14.6% | 0.00% | – |
| Q2 2023 | $338,070 | +43.5% | 4,892 | 0.0% | 0.00% | – |
| Q1 2023 | $235,661 | +60.3% | 4,892 | +65.8% | 0.00% | – |
| Q4 2022 | $146,969 | +21.5% | 2,951 | 0.0% | 0.00% | – |
| Q3 2022 | $121,000 | +33.0% | 2,951 | +78.5% | 0.00% | – |
| Q2 2022 | $91,000 | -7.1% | 1,653 | -38.9% | 0.00% | – |
| Q1 2022 | $98,000 | -22.2% | 2,705 | 0.0% | 0.00% | – |
| Q4 2021 | $126,000 | +4100.0% | 2,705 | +3937.3% | 0.00% | – |
| Q3 2021 | $3,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q2 2021 | $3,000 | +50.0% | 67 | 0.0% | 0.00% | – |
| Q1 2021 | $2,000 | 0.0% | 67 | 0.0% | 0.00% | – |
| Q4 2020 | $2,000 | 0.0% | 67 | +1.5% | 0.00% | – |
| Q3 2020 | $2,000 | -94.6% | 66 | -92.4% | 0.00% | – |
| Q2 2020 | $37,000 | – | 865 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 814,586 | $56,230,872 | 17.46% |
| Paradigm Biocapital Advisors LP | 1,805,717 | $124,648,645 | 9.63% |
| HHLR ADVISORS, LTD. | 6,436,533 | $444,313,873 | 9.46% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,123,692 | $77,568,459 | 9.09% |
| RA Capital Management | 6,264,707 | $432,452,724 | 8.16% |
| Tri Locum Partners LP | 116,768 | $8,060,495 | 3.00% |
| Nicholas Investment Partners, LP | 593,167 | $40,946,318 | 2.80% |
| E Fund Management (Hong Kong) Co., Ltd. | 51,679 | $3,567 | 2.66% |
| Avidity Partners Management LP | 798,900 | $55,148,067 | 1.93% |
| Boxer Capital, LLC | 600,000 | $41,418 | 1.92% |